Neurimmune
Manufacturing · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Wagistrasse 13, Schlieren, Zurich, 8952,...Phone Number
+41 447554646Website
www.neurimmune.comRevenue
$7.3 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Neurimmune
Neurimmune is a biopharmaceutical company focused on translating human immune memory into antibody therapeutics. Their pipeline includes drug candidates for Alzheimer's disease, amyotrophic lateral sclerosis, spinal cord injury, cardiomyopathy, and type 2 diabetes. Utilizing Reverse Translational Medicine technology, they develop therapeutic antibodies with high affinity and target selectivity. Neurimmune aims to help patients worldwide by advancing innovative treatments derived from the immune memories of elderly human donors.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neurimmune your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Neurimmune recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Neurimmune
Check out if Neurimmune is spiking on competitors!
Check if Neurimmune has recently received funding, and reach out quickly before it becomes old news!
Click to see if Neurimmune had a recent Job posting/layoffs
Product Launch: Get notified when Neurimmune launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Neurimmune has new funding data
Neurimmune, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Neurimmune as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Neurimmune is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neurimmune is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neurimmune.
Neurimmune Tech Stack
A closer look at the technologies used by Neurimmune
Neurimmune News & Media
AL-S Pharma Appoints Internationally Recognized Neurologist and Clinical Trial Expert Prof. Dr. Angela Genge as Chief Medical Officer
ZURICH, Sept. 25, 2025 /PRNewswire/ -- AL-S Pharma announced today that it has appointed Angela Genge, MD, Professor of Neurology at McGill University in Montreal, as Chief Medical Officer (CMO). With a distinguished record in amyotrophic lateral sclerosis (ALS) research and the Head of...AL-S Pharma announces positive topline results from Phase 2 study of AP-101 for the treatment of amyotrophic lateral sclerosis (ALS)
Phase 2 of AP-101 in sporadic ALS and mutant SOD1-ALS met its primary safety and tolerability endpoint Clinically meaningful changes in outcome measures and stabilization of biomarkers were observed Data will be presented at upcoming scientific conferences and AL-S Pharma plans to engage...Biogen discontinues Alzheimer's drug Aduhelm
Biogen, maker of the Alzheimer's medicine Aduhelm, announced Wednesday that it would "discontinue the development and commercialization" of the controversial drug.Neurimmune: Promising Phase 1 Results for Antibody NI006 in ATTR Cardiomyopathy Published in the New England Journal of Medicine
Results also presented during late-breaking session at ESC Heart Failure congress 2023
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neurimmune
Sign Up For FreeTo access detailed company insights
Neurimmune is a biopharmaceutical company focused on translating human immune memory into antibody therapeutics. Their pipeline includes drug candidates for Alzheimer's disease, amyotrophic lateral sclerosis, spinal cord injury, cardiomyopathy, and type 2 diabetes. Utilizing Reverse Translational Medicine technology, they develop therapeutic antibo... Read More
